Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
4
×
biogen
biotech
4
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
4
×
national
national blog main
national top stories
4
×
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
4
×
texas blog main
4
×
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
cancer
deals
drug prices
eli lilly
novartis
pfizer
president trump
What
bio
drug
roundup
alzheimer’s
companies
price
prices
acquisitions
albert
annual
approval
assessed
attention
biggest
biogen’s
biopharmaceutical
biotech
bourla
ceo
communities
company
conference
convo
crispr
different
earlier
esmo
europe
fail
failures
future
gene
germany
hosted
imports
increases
investment
latest
littered
maker
Language
unknown
Current search:
medicare
×
startups
×
biotech
×
" alzheimer's disease "
×
" texas blog main "
×
" national top stories "
×
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More